Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

TRUSTMARK CORP (TRMK) Stock Forecast 2025 - AI Price Prediction & Analysis

TRUSTMARK CORP (TRMK) AI Stock Price Forecast & Investment Analysis

TRUSTMARK CORP Stock Price Chart and Technical Analysis

Loading TRUSTMARK CORP interactive price chart and technical analysis...

TRUSTMARK CORP (TRMK) - Comprehensive Stock Analysis & Investment Research

Deep dive into TRUSTMARK CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TRUSTMARK CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TRUSTMARK CORP: TRUSTMARK CORP operates in the Finance sector, establishing it as a mid-cap growth opportunity.

TRUSTMARK CORP (Stock Symbol: TRMK) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

The organization employs approximately 1936 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TRUSTMARK CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TRUSTMARK CORP: With $758M in annual revenue and 23.4% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $758 million generating a 23.4% net profit margin .

Market Capitalization: $2451 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 7.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TRUSTMARK CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For TRUSTMARK CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TRUSTMARK CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TRUSTMARK CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TRUSTMARK CORP: Strong free cash flow generation demonstrates solid operational efficiency.

TRUSTMARK CORP strategically competes in the highly dynamic National Commercial Banks marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $297 million annually, complemented by impressive -43.9% year-over-year cash flow growth.

TRUSTMARK CORP (TRMK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TRUSTMARK CORP stock analysis.

Loading TRUSTMARK CORP comprehensive fundamental analysis and insider trading data...

Deep dive into TRUSTMARK CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TRUSTMARK CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TRUSTMARK CORP: With a P/E ratio of 11.29, the market sees the stock as potentially undervalued.

P/E Ratio 11.29x
P/B Ratio 1.18x
Market Cap $2451M
Dividend Yield 3.17%
EPS $3.57
Book Value/Share $34.01
Revenue/Share $12.46
FCF/Share $1.16
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TRUSTMARK CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TRUSTMARK CORP: An ROE of 7.4% indicates room for improvement in shareholder value creation.

ROE 7.4%
ROA 0.7%
Net Margin 23.4%
EBT Margin 27.8%
Tax Rate 15.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess TRUSTMARK CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TRUSTMARK CORP:

D/E Ratio 0.19x
Financial Leverage 10.69x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TRUSTMARK CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TRUSTMARK CORP: Free cash flow of $297M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $327M
Free Cash Flow $297M
Capital Spending $-30M
OCF Growth YoY -43.9%
FCF Growth YoY -59.7%
FCF/Sales 55.9%
CapEx/Sales 5.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TRUSTMARK CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TRUSTMARK CORP: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Fixed Assets Turnover 2.2x
Understanding Financial Statement Data

What these metrics mean: Key figures from TRUSTMARK CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TRUSTMARK CORP: With annual revenue of $758M, TRUSTMARK CORP demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $758M
SG&A Expense $55M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 28%
Total Liabilities 91%
Short-term Debt 1%
Dividend & Shareholder Information
Dividends Per Share $0.92
Payout Ratio 46.2%
Shares Outstanding 61M
Growth Metrics (YoY)
EPS Growth 8.7%

Latest TRUSTMARK CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TRUSTMARK CORP (TRMK) stock price and investment outlook.

, source: American Banker

Trustmark, in Jackson, Mississippi, says the sale of its Fisher Brown Bottrell Insurance unit to the Marsh McLennan Agency for $345 million would more than offset a $160 million loss it's taking to ...

, source: The Motley Fool

Good morning, ladies and gentleman and welcome to Trustmark Corporation's Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. It is now my ...

TRUSTMARK CORP Competitors & Peer Analysis - Finance Sector

Comparative analysis of TRUSTMARK CORP against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $580M 15.0x 1.1x
AMJB Unlock Forecast - 30 Days FREE Trial $84691M 1.5x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $895M 243.4x 1.0x
AROW Unlock Forecast - 30 Days FREE Trial $487M 15.9x 1.2x
ASRV Unlock Forecast - 30 Days FREE Trial $47M 12.8x 0.4x
ATLO Unlock Forecast - 30 Days FREE Trial $180M 13.1x 0.9x
BAC Unlock Forecast - 30 Days FREE Trial $391343M 13.9x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $196790M 7.0x 0.7x
BAC-PE Unlock Forecast - 30 Days FREE Trial $165328M 5.9x 0.6x
BAC-PK Unlock Forecast - 30 Days FREE Trial $195170M 7.0x 0.7x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9748114M 347.2x 32.5x
BAC-PM Unlock Forecast - 30 Days FREE Trial $176664M 6.3x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $163400M 5.8x 0.6x
BAC-PO Unlock Forecast - 30 Days FREE Trial $144045M 5.1x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $135254M 4.8x 0.5x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $139573M 5.0x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $155304M 5.5x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1912378M 68.1x 6.4x
BANC Unlock Forecast - 30 Days FREE Trial $2756M 18.7x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $4101M 27.8x 1.2x
BANF Unlock Forecast - 30 Days FREE Trial $4526M 19.4x 2.6x
BANFP Unlock Forecast - 30 Days FREE Trial $882M 3.8x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $530M 30.0x 1.0x
BFC Unlock Forecast - 30 Days FREE Trial $1273M 18.4x 2.1x
BHRB Unlock Forecast - 30 Days FREE Trial $937M 9.0x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $159313M 5.7x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $158388M 5.6x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $164711M 5.9x 0.6x
BML-PL Unlock Forecast - 30 Days FREE Trial $159853M 5.7x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8507M 15.9x 1.4x
C Unlock Forecast - 30 Days FREE Trial $189193M 13.4x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $687M 14.0x 1.1x
CARE Unlock Forecast - 30 Days FREE Trial $445M 14.2x 1.1x
CASH Unlock Forecast - 30 Days FREE Trial $1858M 10.8x 2.4x
CBNA Unlock Forecast - 30 Days FREE Trial $201M x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $575M 13.3x 1.5x
CBU Unlock Forecast - 30 Days FREE Trial $3127M 16.1x 1.7x
CFBK Unlock Forecast - 30 Days FREE Trial $156M 8.6x 0.9x
CFR Unlock Forecast - 30 Days FREE Trial $8109M 13.3x 1.9x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1194M 2.0x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1834M 15.0x 2.4x
CMA Unlock Forecast - 30 Days FREE Trial $9141M 12.6x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $143476M 16.5x 1.3x
COF-PI Unlock Forecast - 30 Days FREE Trial $12982M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12515M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $12049M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11383M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11332M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $58067M 4.1x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1354M 30.7x 1.0x
DCOMG Unlock Forecast - 30 Days FREE Trial $1154M 26.2x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $860M 19.5x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $112M 6.5x 0.8x
EVBN Unlock Forecast - 30 Days FREE Trial $220M 15.2x 1.2x
FBMS Unlock Forecast - 30 Days FREE Trial $199M 15.3x 0.2x
FCF Unlock Forecast - 30 Days FREE Trial $1844M 13.8x 1.2x
FDBC Unlock Forecast - 30 Days FREE Trial $254M 10.7x 1.2x
FFBC Unlock Forecast - 30 Days FREE Trial $2507M 10.5x 1.0x
FHN Unlock Forecast - 30 Days FREE Trial $12151M 14.4x 1.4x
FHN-PB Unlock Forecast - 30 Days FREE Trial $13392M 15.9x 1.5x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13545M 16.1x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $13250M 15.7x 1.5x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9965M 11.8x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2638M x 4.4x
FISI Unlock Forecast - 30 Days FREE Trial $557M 8.1x 0.9x
FLIC Unlock Forecast - 30 Days FREE Trial $269M 14.8x 0.7x
FMCB Unlock Forecast - 30 Days FREE Trial $754M 8.4x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5940M 12.7x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $303M 10.1x 1.1x
FRME Unlock Forecast - 30 Days FREE Trial $2344M 10.4x 1.0x
FRMEP Unlock Forecast - 30 Days FREE Trial $1499M 6.6x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1083M 12.2x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3561M 11.0x 1.1x
FULTP Unlock Forecast - 30 Days FREE Trial $3697M 11.4x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $240M 10.1x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $569M 15.8x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $753M 11.5x 1.0x
HBAN Unlock Forecast - 30 Days FREE Trial $26217M 12.4x 1.3x
HBANL Unlock Forecast - 30 Days FREE Trial $38360M 18.2x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $34099M 16.2x 1.6x
HBANP Unlock Forecast - 30 Days FREE Trial $27864M 13.2x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1418M 34.0x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $219M 10.6x 1.4x
JPM Unlock Forecast - 30 Days FREE Trial $858318M 15.2x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71770M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $71068M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $59129M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56349M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57669M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53034M 0.9x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $21283M 120.9x 1.1x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27758M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24925M 141.6x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $25002M 142.1x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27504M 156.3x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $158051M 9685.7x 1065.2x
LCNB Unlock Forecast - 30 Days FREE Trial $228M 10.8x 0.9x
MER-PK Unlock Forecast - 30 Days FREE Trial $199874M 7.1x 0.7x
MFG Unlock Forecast - 30 Days FREE Trial $17584M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $179M 9.8x 1.0x
MZHOF Unlock Forecast - 30 Days FREE Trial $82483M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1469M 12.3x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $2124M 15.9x 1.2x
NEWT Unlock Forecast - 30 Days FREE Trial $313M 5.9x 1.0x
NEWTG Unlock Forecast - 30 Days FREE Trial $651M 12.2x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $655M 12.3x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $2099M 15.5x 1.8x
NKSH Unlock Forecast - 30 Days FREE Trial $198M 17.5x 1.2x
NWBI Unlock Forecast - 30 Days FREE Trial $1610M 11.2x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1059M 12.1x 0.6x
OCFCP Unlock Forecast - 30 Days FREE Trial $1460M 15.2x 0.9x
ONB Unlock Forecast - 30 Days FREE Trial $8812M 15.5x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9882M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9897M 17.4x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $52M 3.6x 0.5x
OPOF Unlock Forecast - 30 Days FREE Trial $215M 24.8x 1.8x
PFIS Unlock Forecast - 30 Days FREE Trial $533M 15.8x 1.1x
PNBK Unlock Forecast - 30 Days FREE Trial $0M -0.7x 0.0x
PNC Unlock Forecast - 30 Days FREE Trial $10M 16.6x 0.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7576M 12.7x 1.1x
PNFPP Unlock Forecast - 30 Days FREE Trial $1934M 3.2x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2753M 16.5x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $24524M 11.8x 1.3x
RF-PC Unlock Forecast - 30 Days FREE Trial $21930M 10.6x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16874M 8.1x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $23354M 11.2x 1.3x
SASR Unlock Forecast - 30 Days FREE Trial $1263M 19.2x 0.8x
SFNC Unlock Forecast - 30 Days FREE Trial $2593M 16.2x 0.7x
SFST Unlock Forecast - 30 Days FREE Trial $366M 16.8x 1.1x
SHBI Unlock Forecast - 30 Days FREE Trial $566M 10.5x 1.0x
SMBK Unlock Forecast - 30 Days FREE Trial $631M 15.1x 1.2x
SNV Unlock Forecast - 30 Days FREE Trial $7278M 9.3x 1.3x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3606M 4.6x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3818M 4.9x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1636M 14.9x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $3615M 16.1x 4.2x
TFC Unlock Forecast - 30 Days FREE Trial $58585M -70.3x 4.1x
TRMK Unlock Forecast - 30 Days FREE Trial $2451M 11.3x 1.2x
UBFO Unlock Forecast - 30 Days FREE Trial $167M 14.9x 1.2x
UBOH Unlock Forecast - 30 Days FREE Trial $114M 10.1x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $9262M 17.5x 1.3x
UMBFO Unlock Forecast - 30 Days FREE Trial $2017M 3.8x 0.3x
UMBFP Unlock Forecast - 30 Days FREE Trial $1898M x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $77513M 11.2x 1.3x
USB-PA Unlock Forecast - 30 Days FREE Trial $1310739M 189.9x 21.3x
USB-PH Unlock Forecast - 30 Days FREE Trial $31983M 4.6x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $38505M 5.6x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $25209M 3.7x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26859M 3.9x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $31197M 4.5x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $218M 12.2x 1.3x
VLY Unlock Forecast - 30 Days FREE Trial $6034M 13.3x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14931M 33.0x 2.0x
VLYPO Unlock Forecast - 30 Days FREE Trial $14221M 31.4x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14480M 32.0x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $74663M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1296M 10.2x 1.4x
WAFD Unlock Forecast - 30 Days FREE Trial $2542M 11.2x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1400M 6.2x 0.5x
WBHC Unlock Forecast - 30 Days FREE Trial $2103M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $10350M 12.1x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3431M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4129M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $270377M 13.1x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5324M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $65190M 3.2x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $60731M 3.0x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $60232M 2.9x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4113064M 199.9x 22.7x
WFC-PY Unlock Forecast - 30 Days FREE Trial $82161M 4.0x 0.5x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $66089M 3.2x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $3060M 22.6x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2416M 17.9x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3252M 12.2x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8399M 10.0x 1.3x
ZIONL Unlock Forecast - 30 Days FREE Trial $3693M 5.8x 0.6x
ZIONO Unlock Forecast - 30 Days FREE Trial $3699M 5.8x 0.6x
ZIONP Unlock Forecast - 30 Days FREE Trial $3395M 4.0x 0.5x

Frequently Asked Questions - TRUSTMARK CORP Stock Forecast

How accurate are TRUSTMARK CORP stock predictions?

Our AI model demonstrates 59% historical accuracy for TRMK predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence TRUSTMARK CORP stock price forecasts?

Our analysis considers TRUSTMARK CORP's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TRUSTMARK CORP a good investment in 2025?

Based on our AI analysis, TRUSTMARK CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TRUSTMARK CORP forecasts updated?

TRUSTMARK CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TRUSTMARK CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TRUSTMARK CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...